PLA2G7 and cardiovascular disorder: Lipoprotein-associated phospholipase A2 (Lp-PLA2), also known as platelet activating factor acetylhydrolase (PAF-AH), is a unique circulating phospholipase that primarily bound to the low-density lipoprotein (approximately 80%) with inflammatory and oxidative activities associated with cardiovascular disease and cerebrovascular events independent of traditional risk factors1, 2, 3.